リピディル錠５３．３ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB01039 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 41 |
| 日本商品名（例） | トライコア錠５３．３ｍｇ, トライコア錠５３．３ｍｇ（選）, トライコア錠８０ｍｇ |
承認適応症（KEGG）
高脂血症、家族性高脂血症
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | hypoalphalipoproteinemia | 99% | DL |
| 2 | homozygous familial hypercholesterolemia | 99% | DL |
| 3 | obsolete familial combined hyperlipidemia | 99% | DL |
| 4 | hyperlipoproteinemia | 99% | DL |
| 5 | familial hypercholesterolemia | 99% | DL |
| 6 | cholesterol-ester transfer protein deficiency | 99% | DL |
| 7 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | 99% | DL |
| 8 | hyperlipidemia | 99% | DL |
| 9 | hyperlipidemia due to hepatic triglyceride lipase deficiency | 99% | DL |
| 10 | familial hyperlipidemia | 99% | DL |
| 11 | hyperlipidemia, familial combined, LPL related | 99% | DL |
| 12 | hypercholesterolemia, autosomal dominant | 99% | DL |
| 13 | hypolipoproteinemia (disease) | 98% | DL |
| 14 | hyperalphalipoproteinemia | 97% | DL |
| 15 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | 96% | DL |
| 16 | HIV infectious disease | 96% | DL |
| 17 | sitosterolemia | 96% | DL |
| 18 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 96% | DL |
| 19 | obsolete susceptibility to ischemic stroke | 96% | DL |
| 20 | brain small vessel disease 1 with or without ocular anomalies | 96% | DL |
| 21 | hypertriglyceridemia, familial | 96% | DL |
| 22 | familial chylomicronemia syndrome | 95% | DL |
| 23 | feline acquired immunodeficiency syndrome | 95% | DL |
| 24 | simian immunodeficiency virus infection | 95% | DL |
| 25 | diabetic nephropathy | 94% | DL |
| 26 | hepatopulmonary syndrome | 93% | DL |
| 27 | primitive portal vein thrombosis | 93% | DL |
| 28 | early-onset familial noncirrhotic portal hypertension | 93% | DL |
| 29 | hepatoportal sclerosis | 93% | DL |
| 30 | idiopathic copper-associated cirrhosis | 93% | DL |
| 31 | cholelithiasis | 93% | DL |
| 32 | hepatic porphyria | 92% | DL |
| 33 | fish eye disease | 92% | DL |
| 34 | brain stem infarction | 92% | DL |
| 35 | congestive heart failure | 91% | DL |
| 36 | fibroma of prostate | 91% | DL |
| 37 | familial hypobetalipoproteinemia | 90% | DL |
| 38 | acute pulmonary heart disease | 90% | DL |
| 39 | Norum disease | 90% | DL |
| 40 | benign reproductive system neoplasm | 90% | DL |
| 41 | hypertriglyceridemia (disease) | 0% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。